Received: from AM7PR04MB6967.eurprd04.prod.outlook.com
 ([fe80::d8a4:db5:f6bd:e76b]) by AM7PR04MB6967.eurprd04.prod.outlook.com
 ([fe80::d8a4:db5:f6bd:e76b%5]) with mapi id 15.20.9275.013; Mon, 3 Nov 2025
 13:56:56 +0000
Received: from mta2.sm.ee (10.11.26.144) by TEHIK-EX01.sotsiaalministeerium.ee
 (10.11.26.101) with Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256) id 15.1.2507.61 via Frontend
 Transport; Mon, 3 Nov 2025 15:57:03 +0200
Received: from AM7PR04MB6967.eurprd04.prod.outlook.com (2603:10a6:20b:108::10)
 by DUZPR04MB9982.eurprd04.prod.outlook.com (2603:10a6:10:4db::21) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9275.15; Mon, 3 Nov
 2025 13:56:57 +0000
Received: from mail-northeuropeazon11022091.outbound.protection.outlook.com (HELO DUZPR83CU001.outbound.protection.outlook.com) ([52.101.66.91])
  by mta.sm.ee with ESMTP/TLS/ECDHE-RSA-AES256-GCM-SHA384; 03 Nov 2025 15:57:02 +0200
Received: from TEHIK-EX01.sotsiaalministeerium.ee (10.11.26.101) by
 TEHIK-EX02.sotsiaalministeerium.ee (10.11.26.102) with Microsoft SMTP Server
 (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256) id
 15.1.2507.61; Mon, 3 Nov 2025 15:57:03 +0200
Received: from TEHIK-EX02.sotsiaalministeerium.ee (10.11.26.102) by
 TEHIK-EX02.sotsiaalministeerium.ee (10.11.26.102) with Microsoft SMTP Server
 (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256) id
 15.1.2507.61 via Mailbox Transport; Mon, 3 Nov 2025 15:57:03 +0200
From: "Legal EE" <legal@euroapteek.ee>
To: <info@terviseamet.ee>
Subject: =?iso-8859-1?Q?Eestis_farmatseudina_registreerimise_l=F5ppemine?=
Date: Mon, 3 Nov 2025 15:56:56 +0200
Message-ID: <AM7PR04MB696774B11352E843EE0710FD92C7A@AM7PR04MB6967.eurprd04.prod.outlook.com>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_0335_01DC4CDB.4B30CB30"
X-Mailer: Microsoft Outlook 16.0
Thread-Index: AQIqS9UqjSDwQbyBRGlxr1zk93hkdA==
X-CSE-ConnectionGUID: Bh2Lpv5tRFm1ugNoN6I2nA==
X-CSE-MsgGUID: BySsvMR5Qs28RAKddyg/Vg==
Authentication-Results: mta.sm.ee; spf=Pass smtp.mailfrom=legal@euroapteek.ee; spf=Pass smtp.helo=postmaster@DUZPR83CU001.outbound.protection.outlook.com; dkim=pass (signature verified) header.i=@euroapteek.ee; dmarc=pass (p=none dis=none) d=euroapteek.ee
X-IPAS-Result: =?us-ascii?q?A0GcAwAxswhpgVtCZTRagQmDDTEqKEABPwJfLwMHCEmII?=
 =?us-ascii?q?QOFLIh4njGBawgHAQEBAQEBAQEBBAECAjcaBAEBAwEDhQACjFQgBgE4EwECA?=
 =?us-ascii?q?QIBAQEBAQMCAwEBAQEBAQEBAQEBCwEBAQQBAQECAQECBAQBAgIQAQEiGQcOO?=
 =?us-ascii?q?4ZPAQyDFoIWLIEWAQwuAQEnARARASUBAQEoBQ8BDgwnBBIBBgIGFIJhgiQEC?=
 =?us-ascii?q?0AEAqR8AYFAAgKLIYE0gQGCDAEBBgQDAQJ+2x2BXQcJgUqCJoIwLWqCZAEqE?=
 =?us-ascii?q?YEhAoJpgV2DRXtCgg0mgTGCOYRyQBWDfoIvgiZ6FIEahQ+IK4o3gWYDWSwBV?=
 =?us-ascii?q?RMXCwcFgWMDKjQtbjIdgSRBGHGBFINJEBFoDwaBEoNRiSYPiUIDC209NxQbB?=
 =?us-ascii?q?QSBNQU7BQUMBQMEBh4BAiyPPxAhDYFGB1SCAYFMEBsnFxVDASsVB0YUCSWTH?=
 =?us-ascii?q?gGPcoF8EJM0jjYVhBEFgV+ILAKCDJIvg0AXhASBV4s8mVSZBiKjGoVaAgQCB?=
 =?us-ascii?q?AUCEAEBBjaBSSOBXIEFgyIJRgMZD1aNVxaBEgECgzXKX0Q0PAIHAQoBAQMJA?=
 =?us-ascii?q?ZMIYAEB?=
X-Talos-CUID: =?us-ascii?q?9a23=3AwJkOPWvV1d12HesEFcD4T1DG6IsPcif51GmNP3W?=
 =?us-ascii?q?WDD90R5uSbwGxoqVNxp8=3D?=
X-Talos-MUID: =?us-ascii?q?9a23=3AbmFYPw2acIVVp62hPAT7NRTsdjUjybWVE14oq8g?=
 =?us-ascii?q?/oJPUDwVTNzuMg3OJTdpy?=
X-IronPort-Anti-Spam-Filtered: true
X-IronPort-AV: E=Sophos;i="6.19,276,1754946000"; 
   d="png'150?scan'150,208,217,150";a="24352043"
X-MGA-submission: =?us-ascii?q?MDHCzDj0y7ukM76QHojTYKZf0pU7HXERJlV0FZ?=
 =?us-ascii?q?QCj8HtAqiTid1WoD0M+9PcBu7EWi23cy4rIIFtZrMMUZ5djUZNqAzLTz?=
 =?us-ascii?q?cFbe+toVHeWM6i4tjFHCFkGvaWTCIjcLYvQm6zUNMIYJxE7528gkpuHG?=
 =?us-ascii?q?0W?=
X-MS-Exchange-Organization-Network-Message-Id: 2f089b91-4e4a-4010-94c7-08de1ae0de2e
X-MS-Exchange-Organization-AVStamp-Enterprise: 1.0
X-MS-Exchange-Organization-AuthSource: TEHIK-EX01.sotsiaalministeerium.ee
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Exchange-Transport-EndToEndLatency: 00:00:00.8077031
X-MS-Exchange-Processed-By-BccFoldering: 15.01.2507.060
X-MS-Has-Attach: yes
X-MS-TNEF-Correlator: 
X-OlkEid: 00000000C2F100042791FD488835E929BC7E6508070034AD76187591974DBF6C4F76951C873A0100020000000000FEAC6C021EAD0E46B13124BDE57E2D4F000000001ABF0000FEC9B1DDE8F97D49B43D8D3F99A4FDD1
x-ms-publictraffictype: Email
x-ms-traffictypediagnostic: AM7PR04MB6967:EE_|DUZPR04MB9982:EE_
x-ms-office365-filtering-correlation-id: d44de4bb-484f-429c-c0fc-08de1ae0d9d6
x-ms-exchange-senderadcheck: 1
x-ms-exchange-antispam-relay: 0
x-microsoft-antispam: BCL:0;ARA:13230040|376014|1800799024|366016|38070700021|4053099003|8096899003;
x-microsoft-antispam-message-info: =?iso-8859-1?Q?RwS/nDcw/8417UlldntMLUUyysepRjgGC/vX2PYO5zeIOQOTcUYSxicCjk?=
 =?iso-8859-1?Q?mFlxX6Xa/AXUZ7wPBqS6uvRMMMnW5NlwSHVHsde4himydnfTmzpd95KTqO?=
 =?iso-8859-1?Q?3G+asAFzTELbK4kHI71UNzoG0xcYSE5TFHm+D4EcVRzOycc0+dJnDk1syk?=
 =?iso-8859-1?Q?qObRyFFC5v7QViTaE7wyQtCBTf6eDOTwMhwiqoyI/YWi2TgYpo7S9dDZVY?=
 =?iso-8859-1?Q?Egdzn5x/sZverTlKqhN/CZ/qSfoU/5ECR6oD/LWWBM0qtklxkT8BITckuP?=
 =?iso-8859-1?Q?OClEO8uxLvR6jSbN5uAMU2QTP59etCHw0dYfY7puqNvTbmjiTyenuYSHCP?=
 =?iso-8859-1?Q?xBrv2gvhQbIjBNKXAHwz5pP/+tkdjcowxBYeK911W4mEDr+d8v5cfS63oL?=
 =?iso-8859-1?Q?Odoj/G9ZFkhApsOH53ji/94P4Dkf7d1SNvEECxlCqkG53CGsrG587+kCVO?=
 =?iso-8859-1?Q?NRF8UWDMcIhkj6gy0qY/LPq0tQtM34Bbp+N8NwMIlhk04BM3tbg+hjhGJ+?=
 =?iso-8859-1?Q?CR2+CE/PYHunAk9PKS9YwK/7L1qMWUawjB7LB5JwtQ1KVdoPtQsKjNoVfE?=
 =?iso-8859-1?Q?K76KPd2Kh9S780OiEqb+Pfc3G7jaZPFW2C0ruQm9EKbtmF3QcmK+CBlVfZ?=
 =?iso-8859-1?Q?UMvmG8nPJiKT5K9/muCmh8bH8k0JDeORkpVcg/3WcUnYw/HifLpCLS7rwA?=
 =?iso-8859-1?Q?CRkAUUCasncfkWeOrPi4743QITbW3IHcSfhMLHzExVGOQcd/d
	nrcN3wFM/?=
 =?iso-8859-1?Q?tMaxtgDW/iYxOJOAhC5FWmjnygX8J+fm/UxnvltEoXTmr72ctIWOGS8sBs?=
 =?iso-8859-1?Q?yoimk5ghOEtx0xiFTdJzd6hI/fJv6/xrUojQHq6jozxCEqBsTUWaBEyPPG?=
 =?iso-8859-1?Q?U78DB/GPXhSBooVIOHUSNwxcxdpoV3mt2YZxYH3wIMumVvQI2aMbyiXzmL?=
 =?iso-8859-1?Q?89IkR14f5Q8REYdgKFff+7rhCf8ubGus9ORxu4jPRZsHO0J1hwsCrevOBb?=
 =?iso-8859-1?Q?pBlvQfmFaN8yqqiKuvPtlS++1JJzfaEtD1dxQkQFQxTVLJnypwsO2I3eio?=
 =?iso-8859-1?Q?s+TSYbU2UY52DuRQ/DtscylNCBwmkHj4cXFCsj/tdwh0O9C+N6YwGtYiKu?=
 =?iso-8859-1?Q?4pAuvbJvzK3tbjkNlXvkKCApTyBjn9nagsR2vnQkbZ8pMzhZnRWAGd9jz0?=
 =?iso-8859-1?Q?bfZVp9e0TiE9NVqmCz/3pHpiroEkb8DeWUJiqwwqQBAJWF8ckUlu41Bq9u?=
 =?iso-8859-1?Q?/GrZBKRIUatFcE/NEVgDdP7S9ADGb4QJ61rdAo5elVPNaAquuQZYkdoV26?=
 =?iso-8859-1?Q?2DFbRh/2pLs3F91RXImGynYsiOF95FIoccLeE17Xx0J/bhDfvXlUIJCuTk?=
 =?iso-8859-1?Q?Jq7QhxkeODT/HvTzYYCYpUhW+1hbLq2WfA3bjIwqJs5w3+iAWk6jN6Ef77?=
 =?iso-8859-1?Q?+HZc0JG84pKeDd/C+E3PzXTLuTzIjcpleZsotMMx3ZW7FbaXKRUAity86t?=
 =?iso-8859-1?Q?ruLeORaXFPVWbE5IienQp7I8ma4TyRlznEn
	68/GWpuRg=3D=3D?=
x-forefront-antispam-report: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:AM7PR04MB6967.eurprd04.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(376014)(1800799024)(366016)(38070700021)(4053099003)(8096899003);DIR:OUT;SFP:1102;
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0: =?iso-8859-1?Q?LavGx980hyG95jgBuy+wJtiTgPE6Jd+Rz5zJ2q5KZsJcdW2r2pxpoyx9w/?=
 =?iso-8859-1?Q?OsDIvhddcGnl2yB3fxiZl2mUKiVHUaWVJ+N3Q9/6d0hQ8AaxR1JeJ5xcWd?=
 =?iso-8859-1?Q?HgshKmIfLFxk5abYl134jEToSAmzbI1XgvcwmMXkqZ/T5VuBOT9ffJc1ql?=
 =?iso-8859-1?Q?sBTYxa9O1Q28LJs2kih7M1RAzGXgLEJQL+0LfQ2VVUZIuzH8X3w1szrdzT?=
 =?iso-8859-1?Q?bEVGfTnUbp1bjRkM0P1PkVRaqmvRAvnpMwm0VmXSXv/fyV/YAQ39GUIMCX?=
 =?iso-8859-1?Q?pl0W4hdvq4rB02DGcruP0iVJraw50Pz9/FAiUbDg93zyTBxZjlzoExqi1J?=
 =?iso-8859-1?Q?iJVKw8MJZ1LBU5nwbQbcqk1JCoyWfpwMpbnPH+4eMmhgGNWGFP/d4DiwrL?=
 =?iso-8859-1?Q?vFsL+Rphu8W7rzu/1RF1IBlMtvJrtahSzud54nLXMGv48M4ZfyR1b78YTR?=
 =?iso-8859-1?Q?QUNb1s2kK7O3V25BtGaEio9lQYiw02YaolI0bvwNTv7hualz5K9IydcsPW?=
 =?iso-8859-1?Q?0Xh3BZo8l4abN7sWwO+I2Lf2Bx92NVZZZ9IfBsmYm95GLsnFRyV4DHMptD?=
 =?iso-8859-1?Q?B8JxpwL+dHpIOGyXePvzKgI/c/dqoQUKfJ/4g1oCfpqwGgWFzHAb2wgfhk?=
 =?iso-8859-1?Q?KMPoQ8QQ2Sxa1SFItxjFPophmu8YzYjlCXgby34sIDP9+lXhXpBevKMNdn?=
 =?iso-8859-1?Q?teovvhTY3RX9pEu6scbksQYLcQm6wRdBoK3ZvAUOxKtzHyzZ6
	5VtzI4kWy?=
 =?iso-8859-1?Q?z0MfFcIiYdMX4wvWhf/MIeJjLbaM9MY35gl/DaqHG4pSeA/WBl4rzj5mkq?=
 =?iso-8859-1?Q?AndfzU2Fc9lM1lQk6Pl+yokd7yPOncYIkvhkomogWQP1X0i16BoUGYD7iw?=
 =?iso-8859-1?Q?I9A1ISW9oEhuLkalUYvAoW2wft4YHr3sU7hxQ/ssbb7OpTYpI1cgct6ZXF?=
 =?iso-8859-1?Q?AWz5UgCmjoHHbcT0ZzEeDc9T7OTNRhFOxSI+HIbPxSiMgiRHdI635fhXB9?=
 =?iso-8859-1?Q?C9uekTuxYr3kPPJzZ9K4M5LB4PFeNpZVul/blKSWNF7d6NQKNU4LrIS0Zg?=
 =?iso-8859-1?Q?GQQguT2Sp4xcW4EzvNf8gaWmHvgBU6vu2uqodu4Njv9kl/Lb8z+DuCfy2H?=
 =?iso-8859-1?Q?5W5YSsNDcJ8JkuUjy4Rh21pAiCNHA9J6+H/bIrOu0xRM5DsmrwzVhqw5+x?=
 =?iso-8859-1?Q?dsUKRhMPsqfFjsC/5M6EWC8BLgPdRPtkopckdR6L4KK5d/bAzDvz1JdCzA?=
 =?iso-8859-1?Q?grDcmGs/eqlDB7tcnDTfVMEfLTCUhTC3smHXIn7/nE6y0+Rg4BKu/goqoC?=
 =?iso-8859-1?Q?mRDmVwdccC1Lr/bsqkwfL6uA7dBOJBWGb2S/GjzhZbHxM7a8B7JPCpjqxq?=
 =?iso-8859-1?Q?ojO9w4WGcNO0XHED74FEV5eiVIcJDEJvF+DnaxpUAAhCnKWuGFTUZISY4d?=
 =?iso-8859-1?Q?ydErtkC5tKMoSFktnbEI2vPIiaRjv8lNhkRLxEZrqt+M9WKmdOO5oFDh8h?=
 =?iso-8859-1?Q?dJKf42Huf34YVEX9rs2V0uaqAkRysoOF1gz
	13NHQ+T2HvDSrUP82LVGN9E?=
 =?iso-8859-1?Q?9BsSRPBpvtsNVKbl6+V8RIFNu/CJkLowLeAyz3n1U4d2yHBS502EmDg/dM?=
 =?iso-8859-1?Q?o1slIP0vUThOpzgHayVZcJW6/3u2tWp7mE?=
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: AM7PR04MB6967.eurprd04.prod.outlook.com
X-MS-Exchange-CrossTenant-Network-Message-Id: d44de4bb-484f-429c-c0fc-08de1ae0d9d6
X-MS-Exchange-CrossTenant-originalarrivaltime: 03 Nov 2025 13:56:56.2650
 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: dcfbcdc8-5abd-44ff-9203-75b04d8bee62
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: +tSTESaHaWL3Ct0sFCceZbjy4GqgzVhrjtvJt+jvtUiKeArzH7xrGxD1qLdkjhpGhv9K+qgIbUK/ie9vepOxMe6DIvOmZKTmGvaHAcFB9XM=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: DUZPR04MB9982
Content-Language: en-us
x-ms-exchange-messagesentrepresentingtype: 1
x-ms-exchange-sharedmailbox-routingagent-processed: True

This is a multipart message in MIME format.

------=_NextPart_000_0335_01DC4CDB.4B30CB30
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_0336_01DC4CDB.4B30CB30"


------=_NextPart_001_0336_01DC4CDB.4B30CB30
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: 8bit


Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.



Lugupeetud Terviseamet

Kirjutame Teile seoses sooviga saada teavet potentsiaalsete tagajärgede
osas seoses farmatseudiks registreerimisega.

Nimelt on tegemist olukorraga, kus Terviseamet on oma otsusega
registreerinud farmatseudi tervishoiukorralduse infosüsteemis. See
tähendab, et eksisteerisid eeldused isiku farmatseudina registreerimiseks,
misjärel Terviseamet luges taotleja kvalifikatsiooni vastavaks. Isiku õpe
ja töökogemus pärinesid Venemaa Föderatsioonist. Pärast kande tegemist on
tekkinud olukord, kus eksisteerib võimalus, et eelnimetatud riik võib
omandatud hariduse (diplomi) tühiseks tunnistada. Olukorras, kui see peaks
juhtuma, kas isikule võivad järgneda tagajärjed ka Eesti riigis? Pean
silmas, kas Terviseamet võib registreeringu tühistada?

Lugupidamisega
Priit Jõks
Jurist / Lawyer
priit.joks@euroapteek.ee
+372 5309 9429



OÜ Euroapteek
Akadeemia tee 45, 13520 Tallinn
euroapteek.ee <http://www.euroapteek.ee/>


The information in this e-mail is confidential and may be legally
privileged. It is intended solely for the addressee(s). Access to this
e-mail by anyone else in unauthorized. If you have received this
communication in error, please notify the original sender immediately by
reply e-mail, then delete the e-mail and destroy any copies of it. If you
are not the intended recipient of this e-mail, any disclosure, copying,
distribution or any action taken or omitted to be taken in reliance on it,
is prohibited and may be unlawful. The internet communications are not
guaranteed to be secure or virus-free and Company does not accept
responsibility for any loss arising from unauthorised access to, or
interference with, any internet communications by any third party, or from
the transmission of any viruses. Replies to this e-mail may be monitored
by the Company for operational or business reasons.


------=_NextPart_001_0336_01DC4CDB.4B30CB30
Content-Type: text/html;
	boundary="_004_AM7PR04MB696774B11352E843EE0710FD92C7AAM7PR04MB6967eurp_";
	charset="iso-8859-1";
	type="multipart/alternative"
Content-Transfer-Encoding: quoted-printable

<html><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Diso-8859-1">
<style type=3D"text/css" style=3D"display:none;"> P =
{margin-top:0;margin-bottom:0;} </style>
</head>
<body dir=3D"ltr"><table class=3D"MsoNormalTable" border=3D"0" =
cellspacing=3D"0" cellpadding=3D"0" align=3D"left" =
style=3D"mso-cellspacing:0cm;mso-yfti-tbllook:1184;mso-table-lspace:2.25p=
t;
 =
mso-table-rspace:2.25pt;mso-table-anchor-vertical:paragraph;mso-table-anc=
hor-horizontal:
 column;mso-table-left:left;mso-padding-alt:0cm 0cm 0cm 0cm">
 <tbody><tr =
style=3D"mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes">
 <td width=3D"100%" =
style=3D"width:100.0%;background:#FFE599;padding:5.25pt 3.75pt 5.25pt =
11.25pt">
 <p =
style=3D"mso-element:frame;mso-element-frame-hspace:2.25pt;mso-element-wr=
ap:
 =
around;mso-element-anchor-vertical:paragraph;mso-element-anchor-horizonta=
l:
 column;mso-height-rule:exactly"><strong><span =
style=3D"font-family:&quot;Arial&quot;,sans-serif;
 color:#212121">T=E4helepanu!</span></strong><span =
style=3D"font-family:&quot;Arial&quot;,sans-serif;
 color:#212121"> Tegemist on v=E4ljastpoolt asutust saabunud kirjaga. =
Tundmatu
 saatja korral palume linke ja faile mitte avada. </span><o:p></o:p></p>
 </td>
 </tr>
</tbody></table><br><span>&nbsp;</span>
<div style=3D"font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 11pt; =
color: rgb(0, 0, 0);" class=3D"elementToProof">
Lugupeetud Terviseamet</div>
<div style=3D"font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 11pt; =
color: rgb(0, 0, 0);" class=3D"elementToProof">
<br>
</div>
<div style=3D"font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 11pt; =
color: rgb(0, 0, 0);" class=3D"elementToProof">
Kirjutame Teile seoses sooviga saada teavet potentsiaalsete =
tagaj=E4rgede osas seoses farmatseudiks registreerimisega.&nbsp;</div>
<div style=3D"font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 11pt; =
color: rgb(0, 0, 0);" class=3D"elementToProof">
<br>
</div>
<div style=3D"font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 11pt; =
color: rgb(0, 0, 0);" class=3D"elementToProof">
Nimelt on tegemist olukorraga, kus Terviseamet on oma otsusega =
registreerinud farmatseudi tervishoiukorralduse infos=FCsteemis. See =
t=E4hendab, et eksisteerisid eeldused isiku farmatseudina =
registreerimiseks, misj=E4rel Terviseamet luges taotleja =
kvalifikatsiooni
 vastavaks. Isiku =F5pe ja t=F6=F6kogemus p=E4rinesid Venemaa =
F=F6deratsioonist. P=E4rast kande tegemist on tekkinud olukord, kus =
eksisteerib v=F5imalus, et eelnimetatud riik v=F5ib omandatud hariduse =
(diplomi) t=FChiseks tunnistada. Olukorras, kui see peaks juhtuma, kas =
isikule
 v=F5ivad j=E4rgneda tagaj=E4rjed ka Eesti riigis? Pean silmas, kas =
Terviseamet v=F5ib registreeringu t=FChistada?&nbsp;</div>
<div style=3D"font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 11pt; =
color: rgb(0, 0, 0);" class=3D"elementToProof">
<br>
</div>
<div style=3D"font-family: Aptos, Aptos_EmbeddedFont, =
Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 11pt; =
color: rgb(0, 0, 0);" class=3D"elementToProof">
Lugupidamisega</div>
<div class=3D"elementToProof" id=3D"Signature">
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm; =
font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, =
Helvetica, sans-serif; font-size: 11pt; color: rgb(0, 0, 0);" =
class=3D"elementToProof">
<b>Priit J=F5ks</b></div>
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm 0cm 3pt; =
font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, =
Helvetica, sans-serif; font-size: 11pt; color: rgb(0, 0, 0);" =
class=3D"elementToProof">
Jurist / Lawyer</div>
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm 0cm 3pt; =
font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, =
Helvetica, sans-serif; font-size: 11pt; color: rgb(0, 0, 0);" =
class=3D"elementToProof">
priit.joks@euroapteek.ee&nbsp;</div>
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm; =
font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, =
Helvetica, sans-serif; font-size: 11pt; color: rgb(0, 0, 0);" =
class=3D"elementToProof">
&#43;372 5309 9429</div>
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm; =
font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, =
Helvetica, sans-serif; font-size: 11pt; color: rgb(0, 0, 0);" =
class=3D"elementToProof">
&nbsp;</div>
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm; =
font-family: Calibri, sans-serif; font-size: 16px; color: rgb(36, 36, =
36);" class=3D"elementToProof">
<span style=3D"background-color: rgb(255, 255, 255);"><img =
style=3D"width: 1.2333in; height: 0.2916in; max-width: 417px; min-width: =
auto; min-height: auto; margin: 0px;" height=3D"27" width=3D"118" =
data-olk-copy-source=3D"MessageBody" id=3D"x_Picture_x0020_4" =
data-outlook-trace=3D"F:1|T:1" =
src=3D"cid:b1ad1e36-655b-4463-9efd-fdbc8c7070f3"></span></div>
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm; =
font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, =
Helvetica, sans-serif; font-size: 11pt; color: rgb(0, 0, 0);" =
class=3D"elementToProof">
<br>
</div>
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm; =
font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, =
Helvetica, sans-serif; font-size: 11pt; color: rgb(0, 0, 0);" =
class=3D"elementToProof">
<b>O=DC Euroapteek</b></div>
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm; =
font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, =
Helvetica, sans-serif; font-size: 11pt; color: rgb(0, 0, 0);" =
class=3D"elementToProof">
Akadeemia tee 45, 13520 Tallinn</div>
<div style=3D"text-align: left; text-indent: 0px; margin: 0cm; =
font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, =
Helvetica, sans-serif; font-size: 11pt; color: rgb(5, 99, 193);" =
class=3D"elementToProof">
<a style=3D"color: rgb(5, 99, 193); margin: 0px;" data-linkindex=3D"2" =
data-auth=3D"NotApplicable" title=3D"http://www.euroapteek.ee/" =
class=3D"OWAAutoLink" id=3D"OWA6d244970-79d6-5e1d-6ce9-af67ae8cbbd0" =
href=3D"http://www.euroapteek.ee/">euroapteek.ee</a></div>
</div>
<div style=3D"font-size:9pt;  font-family: 'Calibri',sans-serif;"><br>
<br>
The information in this e-mail is confidential and may be legally =
privileged. It is intended solely for the addressee(s). Access to this =
e-mail by anyone else in unauthorized. If you have received this =
communication in error, please notify the original sender
 immediately by reply e-mail, then delete the e-mail and destroy any =
copies of it. If you are not the intended recipient of this e-mail, any =
disclosure, copying, distribution or any action taken or omitted to be =
taken in reliance on it, is prohibited and may
 be unlawful. The internet communications are not guaranteed to be =
secure or virus-free and Company does not accept responsibility for any =
loss arising from unauthorised access to, or interference with, any =
internet communications by any third party, or from
 the transmission of any viruses. Replies to this e-mail may be =
monitored by the Company for operational or business reasons.<br>
</div>
</body>
</html>

------=_NextPart_001_0336_01DC4CDB.4B30CB30--

------=_NextPart_000_0335_01DC4CDB.4B30CB30
Content-Type: image/png;
	name="Outlook-bf3gclmz.png"
Content-Transfer-Encoding: base64
Content-ID: <b1ad1e36-655b-4463-9efd-fdbc8c7070f3>
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------=_NextPart_000_0335_01DC4CDB.4B30CB30--
